Pošalji slijedeće na WhatsApp
Nastavi za razgovorhttps://www.marketscreener.com/quote/stock/ANAPTYSBIO-INC-33634949/news/Anaptysbio-and-GSK-Partnered-Immuno-Oncology-Agent-Jemperli-Dostarlimab-Gxly-Meets-Primary-Endpoi-42467083/?utm_source=whatsapp&utm_medium=social&utm_campaign=share